New powerful database to help prevent asthma in children

Imagine a world where allergies, asthma and related chronic diseases are rare. Better yet, imagine a world where these conditions can be prevented before they even develop.

A new powerful database being developed by SFU genomics and bioinformatics researcher Fiona Brinkman and her team is helping Canadian researchers make that world a reality.

In the Canadian Healthy Infant Longitudinal Development (CHILD) study, researchers will use the database, called CHILDdb, to look in depth at how genes and the environment interact to cause chronic diseases in children, in particular allergic disease like asthma. Over 3500 Canadian children are having diverse data tracked about them from birth to age 8.

The CHILD researchers, including SFU researcher Tim Takaro, will use the rich data from CHILDdb to develop precision medicine, which will enable earlier diagnoses and prevention of allergic disease, in particular asthma, in children.

Today, asthma is the most common chronic childhood disease, affecting 1 in 7 Canadian children. It is the number one reason for children to be admitted to hospital, and the most common reason for children to miss school. The total cost of asthma in Canada is estimated at over $2 billion annually.

The development of this new powerful bioinformatics database is made possible through $9.1 million in support from Genome Canada for the CHILD study, with the support of SFU's new Data Hub.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
COVID-19 vaccination linked to reduced symptomatic child asthma